Polycystic Ovary Syndrome and Psychotic Disorder-Reference-Cited by-同舟云学术

Polycystic Ovary Syndrome and Psychotic Disorder

Published:2020-06-10 Issue: Volume:11 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Doretto Larissa,Mari Flora Chaves,Chaves Ana Cristina

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference49 articles.

1. Criteria, prevalence, and phenotypes of polycystic ovary syndrome;Lizneva,2016

2. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. National Health and Medical Research Council (NHMRC);Teede,2018

3. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort;Cesta;Psychoneuroendocrinology.,2016

4. Polycystic ovary syndrome and mental disorders: A systematic review and exploratory meta-analysis;Blay;Neuropsychiatr Dis Treat,2016

5. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence;Ibáñez,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of premenstrual symptoms, psychological well-being, and nutritional status between Palestinian women with and without polycystic ovarian syndrome: a case-control study;BMC Women's Health;2024-06-21

2. Polycystic ovary syndrome and the rs10818854 and rs10986105 variants of the DENND1A gene: An association study among Bangladeshi women;Gene Reports;2024-06

3. SÍNDROME DOS OVÁRIOS POLICÍSTICOS: ALIMENTAÇÃO E A PRÁTICA ESPORTIVA;REVISTA FOCO;2024-04-18

4. Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF1/p-AKT/FOXO1 and NFκB/IL-1β/TNF-α signaling pathways in female Wistar albino rats;Biochemical Pharmacology;2024-03

5. Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial;BMC Women's Health;2024-01-03